A new pet for myeloma
- PMID: 19729530
- DOI: 10.1182/blood-2009-06-224196
A new pet for myeloma
Abstract
In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.
Comment on
-
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.Blood. 2009 Sep 3;114(10):2068-76. doi: 10.1182/blood-2009-03-213280. Epub 2009 May 14. Blood. 2009. PMID: 19443657 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources

